Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia.
Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD 4072, Australia.
Adv Drug Deliv Rev. 2022 Jan;180:114031. doi: 10.1016/j.addr.2021.114031. Epub 2021 Nov 1.
Dynamic drug delivery systems (DDSs) have the ability of transforming their morphology and functionality in response to the biological microenvironments at the disease site and/or external stimuli, show spatio-temporally controllable drug delivery, and enhance the treatment efficacy. Due to the large surface area and modification flexibility, two-dimensional (2D) inorganic nanomaterials are being increasingly exploited for developing intelligent DDSs for biomedical applications. In this review, we summarize the engineering methodologies used to construct transformable 2D DDSs, including changing compositions, creating defects, and surface dot-coating with polymers, biomolecules, or nanodots. Then we present and discuss dynamic inorganic 2D DDSs whose transformation is driven by the diseased characteristics, such as pH gradient, redox, hypoxia, and enzyme in the tumor microenvironment as well as the external stimuli including light, magnetism, and ultrasound. Finally, the limitations and challenges of current transformable inorganic DDSs for clinical translation and their in vivo safety assessment are discussed.
动态药物传递系统(DDSs)具有在疾病部位的生物微环境和/或外部刺激下响应变化形态和功能的能力,表现出时空可控的药物传递,并提高治疗效果。由于具有较大的表面积和修饰灵活性,二维(2D)无机纳米材料正越来越多地被用于开发用于生物医学应用的智能 DDS。在这篇综述中,我们总结了用于构建可变形 2D DDS 的工程方法,包括改变组成、创建缺陷以及用聚合物、生物分子或纳米点对表面进行点状涂覆。然后,我们介绍并讨论了由肿瘤微环境中的疾病特征(如 pH 梯度、氧化还原、缺氧和酶)以及包括光、磁和超声在内的外部刺激驱动的动态无机 2D DDS 的转化。最后,讨论了当前可变形无机 DDS 用于临床转化及其体内安全性评估的局限性和挑战。